Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eisert

Showing results (441-450 of 483) with videos related to

Pageof 49
Sort By:
EJNMMI Research|January 17, 2023
Vessel-by-vessel analysis of lower extremity <sup>18</sup>F-NaF PET/CT imaging quantifies diabetes- and chronic kidney disease-induced active microcalcification in patients with peripheral arterial diseaseTing-Heng Chou, Eleanor T Rimmerman, Surina Patel, et al.
Hamostaseologie|November 5, 2008
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia AI Wieland, C Wermes, B Eifrig, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
HUWE1 Amplifies Ubiquitin Modifications to Broadly Stimulate Clearance of Proteins and AggregatesMengying Zhou, Rui Fang, Louis Colson, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scoresMargitta Worm, Miriam Zidane, Lisa Eisert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes - Teil 2: Therapie, Risikofaktoren und spezielle FragestellungenMargitta Worm, Miriam Zidane, Lisa Eisert, et al.
Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate CancerFu Gui, Baishan Jiang, Jie Jiang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 2, 2021
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 2: Therapy, risk factors and other special topicsMargitta Worm, Miriam Zidane, Lisa Eisert, et al.
Viruses|February 26, 2022
Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific AntiseraMarie-Luise Herrlein, Sascha Hein, Tobias Zahn, et al.
Nature Communications|January 2, 2025
Verifiable measurement-based quantum random sampling with trapped ionsMartin Ringbauer, Marcel Hinsche, Thomas Feldker, et al.
Pageof 49

Showing results (441-450 of 483) with videos related to

Sort By:
Pageof 49
EJNMMI Research|January 17, 2023
Vessel-by-vessel analysis of lower extremity <sup>18</sup>F-NaF PET/CT imaging quantifies diabetes- and chronic kidney disease-induced active microcalcification in patients with peripheral arterial diseaseTing-Heng Chou, Eleanor T Rimmerman, Surina Patel, et al.
Hamostaseologie|November 5, 2008
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia AI Wieland, C Wermes, B Eifrig, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
HUWE1 Amplifies Ubiquitin Modifications to Broadly Stimulate Clearance of Proteins and AggregatesMengying Zhou, Rui Fang, Louis Colson, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scoresMargitta Worm, Miriam Zidane, Lisa Eisert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes - Teil 2: Therapie, Risikofaktoren und spezielle FragestellungenMargitta Worm, Miriam Zidane, Lisa Eisert, et al.
Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate CancerFu Gui, Baishan Jiang, Jie Jiang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 2, 2021
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 2: Therapy, risk factors and other special topicsMargitta Worm, Miriam Zidane, Lisa Eisert, et al.
Viruses|February 26, 2022
Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific AntiseraMarie-Luise Herrlein, Sascha Hein, Tobias Zahn, et al.
Nature Communications|January 2, 2025
Verifiable measurement-based quantum random sampling with trapped ionsMartin Ringbauer, Marcel Hinsche, Thomas Feldker, et al.
Pageof 49